COMMUNIQUÉS West-GlobeNewswire

NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
20/11/2025
BELTSVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to [...]
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
20/11/2025
Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program combining these novel AI- [...]
Catheter Precision Announces Successful LockeT Launch in South Africa
20/11/2025
FORT MILL, S.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]
Valitor Announces Upcoming Presentation at the 15th Annual Ophthalmology Innovation Summit (OIS)
20/11/2025
BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its chief executive officer, Gregory D. Kunst, will present [...]
Opus Genetics to Participate in Upcoming Investment Conferences
20/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results
20/11/2025
– Post-implantation analysis of ATEVs demonstrates progressive recellularization with host cells, transforming the ATEV into a multi-layered living tissue similar to that of native blood vessels – – Positive outcomes [...]
Persephone Biosciences Announces Positive Topline Results from ARTEMIS Clinical Trial of First-of-its-kind Synbiotic for Children
20/11/2025
- 114 infants and toddlers received Persephone’s synbiotic or placebo - - The study generated important, positive clinical data on colonization and sleep improvement, after just 30 days of treatment - - Persephone’s [...]
4DMT to Participate in 8th Annual Evercore Healthcare Conference
20/11/2025
EMERYVILLE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
20/11/2025
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update
20/11/2025
Management to host conference call and webcast Thursday, November 20 , 2025, at 8:30 AM ET Company advances commercialization and is on track to meet year-end system deployment target PETAH TIKVA, Israel, Nov. 20, 2025 [...]
Shattuck Labs to Participate in Upcoming December Investor Conferences
20/11/2025
AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics [...]
Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference
20/11/2025
SALT LAKE CITY, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Johns Hopkins Health Plans Welcomes Inova Health To Medicare Advantage Network
20/11/2025
Relationship Enhances Care Access as Advantage MD Expands Virginia Service Area HANOVER, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Effective Jan. 1, 2026, Virginia-based Inova Health will be an in-network provider for [...]
Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
20/11/2025
VANCOUVER, British Columbia and LAS VEGAS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) today announced it ranked No. 77 on the 2025 [...]
23andMe Research Institute Helps Reconnect African Diaspora to Their Roots with Release of 250+ High-Resolution African Genetic Groups
20/11/2025
Major Scientific Expansion Provides the Most Detailed Look at African Ancestry on the Market, Helping to Bypass Historical 'Brick Walls' for Individuals with African Heritage PALO ALTO, Calif., Nov. 20, 2025 (GLOBE [...]
Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer
20/11/2025
Veteran CFO appointment underscores the Company’s commitment to building a strong leadership team as it advances its clinical and commercial strategy TEL AVIV, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: [...]
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
20/11/2025
AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (GAAP) are emerging [...]
Bonk, Inc. Reports Q3 Financial Results: Emerges Debt-Free with $9 Million in Cash and 1,200% Revenue Growth
20/11/2025
Strategic Transformation Complete: Company Settles Legacy Obligations, Achieves First-Ever Gross Profit in Beverage Segment, and Accelerates Path to Cash Flow Positivity SCOTTSDALE, AZ, Nov. 20, 2025 (GLOBE NEWSWIRE [...]
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes
20/11/2025
New Taipei City, Taiwan, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and [...]

Pages